November 2011 Issue of MMM
November 2011 Issue
Is pharma catching up with technology or are companies still marketing like it's 1999?
Almost 700 of the industry's brightest stars came to New York's Cipriani 42nd Street for the sold-out MM&M Awards 2011 dinner and ceremony.
Seeking part of the primary care market, specialty and biotech firms are filling the void being left by Big Pharma. Marc Iskowitz on the strategies ...
As pressure mounts on the industry, it's more important to make the agency-client relationship work. James Chase and Marc Iskowitz ask agency leaders and pharma ...
Manny Hernandez, the founder of Diabetes Hands Foundation, has partnered with pharma companies on education and support programs
Unbranded campaigns provide an effective approach to creating a meaningful disruption in the marketplace, and give your agency another outlet to showcase its strategic, scientific, ...
Comparative Effectiveness Research (CER) is becomimg a key element in assessing the value of healthcare products.
In two studies, the PSA was found to lower the prostate cancer death rate by more than 30 percent
After Facebook's decision on August 15 to enforce open walls on the site's pharma pages, companies had two options: close down their pages altogether, or ...
Will Xarelto become the first Factor Xa inhibitor with an indication for use in patients who have had a heart attack or similar symptoms?
ImpactRx, a firm that measures the impact of promotional materials on physician prescribing behavior, has launched TabletImpact, an analytical tool for pharma sales representatives.
News on Pfizer, Sucampo Pharma Americas, Manhattan Research, Physicians Proviso and Marken
Med Ed Report
Stanford's new Center for Medical Education Research and Innovation, initially tasked with exploring ways of delivering undergraduate and graduate medical education, could also help Stanford's ...
Researchers evaluating diabetes and high cholesterol screening and treatment guidelines found that guideline-panel members are pervaded by financial conflicts of interest.
As pharmaceutical companies cut spending on other marketing areas, meetings stay a primary channel for gaining physician mindshare, data show.
News on the National Commission for Certification of CME Professionals, the Alliance for CME, KnowledgePoint360 Group, the CME Coalition and the American College of Physician ...
Healthcare communications network KnowledgePoint360 has expanded its roster of health strategy tools with "My Virtual How" (MyVHow), a tool designed to benchmark best practices for ...
A report from investment bank Berkery Noyes on M&A in information and tech companies serving pharma and healthcare says third-quarter transaction volume slowed 6% vs. ...
News on PDR Network, Elsevier, the American College of Cardiology, AF Stat: A Call to Action for Atrial Fibrillation, Publicis Healthware International and dotSUB
What are the implications of personalized medicine for media? Do more targeted therapies mean a precipitous drop in ad spend, or will spending migrate to ...
Asking consumers to gauge their non-adherence risk, Merck has added a one-minute survey dubbed the Adherence Estimator to its education and awareness site, MerckEngage.com.
Double the number of MDs used the consumer search engine (87%) for professional research online as the next most-used search options (WebMD and PubMed, each ...
News on Takeda Pharmaceuticals North America, the American Association of Clinical Endocrinologists, Elsevier and Mayo Clinic
Branko the Prostate Czech has been wielding his latex glove to raise awareness in a public service effort being funded by consumer shop Kirshenbaum Bond ...
Organon/Merck has launched a DTC campaign for its NuvaRing female contraceptive, and it does a good job announcing the brand despite several challenges.
As the market for syndicated video heats up, Roku signed a deal enabling its TV set-top players to stream programs from HealthiNation.
A survey by Yahoo! and ad giant BBDO says advertisers need to raise their game in "owned media" like brand.com sites to woo consumers.
Defensive tackle-turned-sports radio talker Mike Golic has signed on to Merck and the American College of Endocrinology's Blood Sugar Basics awareness campaign, which emphasizes the ...
News on the AMA, Clearasil and Euro RSCG Worldwide
IMS Health continues to assess a data-supply glitch that led to an underreporting of prescriptions for Vertex Pharmaceuticals' hepatitis C drug Incivek.
More than half of drug companies plan to increase spending for market-access activities in 2012, including comparative effectiveness research (CER), according to a report from ...
Publicis Healthcare Communications Group has named Anders Ekman managing director of Saatchi & Saatchi Health Communications New York, the flagship professional healthcare agency of the ...
New York indie agency Concentric Pharma Advertising announced that business transfer organization MDC Partners has acquired a majority stake in the firm.
News on Euro RSCG Worldwide, Publicis Healthcare Communications Group, Ogilvy CommonHealth and Publicis Healthware International
Anti-corporation protests on Wall Street and beyond send a message that pharmaceutical marketers and regulators alike should ponder.
Working with the private-public Biomarkers Consortium at the Foundation for the National Institutes of Health, FDA is looking at options to ease the development path ...
Briefs filed in recent off-label marketing cases continue the confusion that exists in defining acceptable practices for drug and medical device companies.
Today, for the top performers from Generation X & Y, it's no longer enough to hunt with the pack
Marketers can acquire critical knowledge by identifying keywords that align with relevant issues
Name That Brand
Pharmaceutical companies have not moved nearly fast enough to keep up with their customers' digital preferences
- Sunovion hires former BI exec as VP of marketing
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Tuesday, October 25, 2016
- Five things for pharma marketers to know: Monday, October 24, 2016
- Five things for pharma marketers to know: Wednesday, October 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy